BMJ Oncology (Dec 2023)

Nivolumab in salivary gland cancers: confronting the challenges of unlocking the therapeutic benefits of immunotherapy for rare diseases

  • Antoine Desilets,
  • Alan L Ho

DOI
https://doi.org/10.1136/bmjonc-2023-000214
Journal volume & issue
Vol. 2, no. 1

Abstract

Read online

No abstracts available.